phosphatidylcholines has been researched along with cupric acetate in 4 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (cupric acetate) | Trials (cupric acetate) | Recent Studies (post-2010) (cupric acetate) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 82 | 0 | 26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotton, DB; Gonik, B; Spillman, T | 1 |
| Beers, PC; Dobbins, MF; Gabbe, SG; Levin, SS; Matthews, L; Touchstone, JC | 1 |
| Bretaudiere, JP; Cotton, DB; Lynn, SC; Spillman, T | 1 |
| Bally, MB; Edwards, K; Hare, JI; Kapanen, AI; Karlsson, G; Ramsay, E; Thomas, AM | 1 |
4 other study(ies) available for phosphatidylcholines and cupric acetate
| Article | Year |
|---|---|
Effect of differences in saturation sensitivity of phospholipid stains on clinical predictivity of L/S ratios.
Topics: Amniotic Fluid; Copper; Female; Humans; Infant, Newborn; Organometallic Compounds; Phosphatidylcholines; Phospholipids; Pregnancy; Prenatal Diagnosis; Respiratory Distress Syndrome, Newborn; Sphingomyelins; Staining and Labeling | 1985 |
(3-sn-Phosphatidyl)cholines (lecithins) in amniotic fluid.
Topics: Amniotic Fluid; Chromatography, Thin Layer; Copper; Copper Sulfate; Female; Fetal Diseases; Gestational Age; Humans; Infant, Newborn; Organometallic Compounds; Phosphatidylcholines; Pregnancy; Prenatal Diagnosis; Respiratory Distress Syndrome, Newborn; Sphingomyelins | 1983 |
Influence of phospholipid saturation on classical thin-layer chromatographic detection methods and its effect on amniotic fluid lecithin/sphingomyelin ratio determinations.
Topics: Amniotic Fluid; Chromatography, Thin Layer; Copper; Fatty Acids, Unsaturated; Female; Humans; Methods; Molybdenum; Organometallic Compounds; Phosphatidylcholines; Phospholipids; Phosphoric Acids; Pregnancy; Sphingomyelins | 1983 |
Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
Topics: Animals; Biological Availability; Body Weight; Cell Survival; Cholesterol; DNA-Binding Proteins; Drug Delivery Systems; Drug Stability; Female; Fluorouracil; HT29 Cells; Humans; Inhibitory Concentration 50; Injections, Intraperitoneal; Liposomes; Mice; Mice, Inbred BALB C; Mice, Knockout; Microscopy, Electron, Transmission; Neoplasms; Organometallic Compounds; Particle Size; Phosphatidylcholines; Polyethyleneimine; Static Electricity; Treatment Outcome; Xenograft Model Antitumor Assays | 2011 |